# K252722: Biopsy Forceps

- Pathway: 510(k) (Special)
- Applicant: Fehling Instruments GmbH
- Decided: Sep 30, 2025 after 33 days
- Product code: DWZ (Device, Biopsy, Endomyocardial)
- Device class: 2
- Regulation: 21 CFR 870.4075
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K870186 (1987). 4 ancestors in all.
No later device cites it as a predicate yet.
0 of 5 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K170726: Biopsy Forceps, Fehling Instruments GmbH & Co. KG (2017) Summary page 5.

## Indications for use
FEHLING Biopsy Forceps are used to obtain endomyocardial biopsy specimens from the right and left ventricle via percutaneous arterial or venous approach.

Source page: https://510kreport.com/device/K252722
Methodology: https://510kreport.com/methodology